COVID vaccines being made in India due to our efficient production venue: EAM Jaishankar ANI | Updated: May 05, 2021 14:07 IST London [UK], May 5 (ANI): External Affairs Minister (EAM) S Jaishankar on Wednesday explained the difference between India's vaccine "production situation", from that of the US and said Covishield is being made in India due to its efficient production venue. Speaking at a Global Dialogue Series event, Jaishankar said, "On what basis Covishield was being made in India? It's the Oxford-AstraZeneca vaccine, you can say it's a British-designed product. It was made in India as vaccine owner saw India as an efficient production venue."